CFGS
CNST

Concourse Financial Group Securities’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Concourse Financial Group Securities’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-500
Closed -$4.17K – 2247
2019
Q2 		$6K Buy
+500
New +$5.57K ﹤0.01% 1704

Other funds holding CNST

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
ROTUOC
Regents of the University of California Oakland, California $3.01B AUM 11.91% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Concourse Financial Group Securities's CNST Position: Q3 2019 in Review

Concourse Financial Group Securities sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2019, closing a stake of 500 shares — an estimated $4.17K sold.

Concourse Financial Group Securities first reported a position in CNST in Q2 2019 and held it in 1 quarter. The position peaked at $6K in Q2 2019. 48 funds tracked by Wall St. Rank hold CNST as of Q3 2019.

  • Concourse Financial Group Securities reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Concourse Financial Group Securities sold 500 Constellation Pharmaceuticals, Inc. shares in Q3 2019, an estimated $4.17K.
  • Concourse Financial Group Securities first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2019 and held it in 1 quarter.
  • Concourse Financial Group Securities's Constellation Pharmaceuticals, Inc. position peaked at $6K in Q2 2019.
  • 48 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2019.

Based on Concourse Financial Group Securities's 13F filing for Q3 2019, filed 13 Nov 2019.